Moody’s warns global medicine supply chains face sustained instability, with Red Sea disruptions, rising tariffs and API dependence threatening drug costs and availability. | Collector
Gulf News
Moody’s warns global medicine supply chains face sustained instability, with Red Sea disruptions, rising tariffs and API dependence threatening drug costs and availability.
Moody’s warns global medicine supply chains face sustained instability, with Red Sea disruptions, rising tariffs and API dependence threatening drug costs and availability.